February 11, 2020 / 7:13 AM / 13 days ago

BRIEF-Moberg Pharma Q2 EBITDA Loss Narrows To SEK 4.2 Million

Feb 11 (Reuters) - Moberg Pharma AB (publ):

* Q2 NET REVENUE SEK 2.7 MILLION (0.0)

* Q2 EBITDA SEK -4.2 MILLION (-10.3) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below